Registered in the ESID database by ESID documenting centers (incl. national centers)
| Documented by 117 centers | ||
| 2013 |  | (n=18,259) |
| Documented by 96 centers | ||
| 2012 |  | (n=16,547) |
| Documented by 88 centers | ||
| 2011 |  | (n=15,052) |
| Documented by 73 centers | ||
| 2010 |  | (n=13,017) |
| Documented by 64 centers | ||
| 2009 |  | (n=10,747) |
| Documented by 54 centers | ||
| 2008 |  | (n=7,550) |
| Documented by 47 centers | ||
| 2007 |  | (n=5,514) |
| Documented by 37 centers | ||
| 2006 |  | (n=3,047) |
| Documented by 26 centers | ||
| 2005 |  | (n=1,173) |
| Documented by 19 centers | ||
| 2004 |  | (n=154) |
| Male | | Female | | Unknown |
Living patients (n) per 100,000 inhibitants
(Move mouse over map for more details (Country, number of living patients, prevalence)
|
Note (1): The map shows the minimal prevalence rates calculated from the number of documented PID patients in the ESID Database.
Note (2): There are patients who are treated outside their country of residence. This means that e.g. a patient is registered by a hospital in Switzerland though he lives in Austria.
